IMRN

#5144
Immuron Limited American Depositary Shares
0.77
-8.33%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
0.77
0.77
Jahresspanne
0.68
2.38
Tagesänderung
-8.33%
Monatliche Änderung
-20.62%
6 month change
-56.25%
Jahresänderung
-59.90%
Vorheriger Schlusskurs
0.84
Open
0.77
Bid
Ask
Low
0.77
High
0.77
Volumen
1
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
Value Q4, 24 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Immuron Limited - American Depositary Shares

Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited. Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment. In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market.

Nachrichten